Industry News
Patients, especially children, who undergo blood transfusions in sub-Saharan Africa are at high risk of transfusion-transmitted malaria.
Identification of therapeutic targets in multiple myeloma
4/22/2016
Multiple myeloma (MM) is a hematological cancer that frequently acquires resistance to chemotherapeutic drugs.
New radiotherapies to target cancer more effectively in the UK
4/22/2016
Safer precision radiotherapies that will be able to cure more cancers with fewer side-effects will be available within five years under ambitious new plans for research and treatment at the UCL...
Regenstrief, IU study finds machine learning as good as humans' in cancer surveillance
4/22/2016
Machine learning has come of age in public health reporting according to researchers from the Regenstrief Institute and Indiana University School of Informatics and Computing at Indiana...
CD2 molecule triggers cancer recognition in natural killer cells
4/21/2016
A study coordinated by the Malmberg Laboratory at Oslo University Hospital/University of Oslo and the Karolinska Institute, published in Cell Reports, reveals a molecule that trigger cancer...
Amgen has announced that The Lancet published results from a Phase 3 randomized, double-blind, placebo-controlled study of Nplate® (romiplostim) in children with symptomatic immune...
Precision medicine: is it becoming a reality for childhood cancer?
4/21/2016
For adults with cancer, precision medicine has emerged as a feasible treatment option. Unfortunately, the same cannot be said for childhood cancer. But is this changing?
New data analyses found no association between anthracycline chemotherapy and greater risk of cognitive decline in breast cancer survivors, according to an article published online by JAMA Oncology.
In a study published online by JAMA Cardiology, Fredrik Björck, M.D., of Umea University, Umea, Sweden and colleagues evaluated the efficacy and safety of well-managed warfarin therapy in patients...
Unconventional antibody defends blood vessels against sepsis
4/21/2016
An antibody that defends blood vessels against sepsis can prevent mice from succumbing to the disease, a new study shows.